Cartrade Tech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 10:01 pm

Quick Insight

Cartrade Tech Ltd, with a market capitalization of ₹11,098 Cr., is trading at a P/E of 71.5, indicating investor optimism despite a modest ROE of 6.28% and ROCE of 7.61%. The company's OPM stands at a healthy 25%, supporting its Net Profit of ₹145 Cr. The shareholding pattern reveals significant FII interest at 51.63%, followed by DIIs at 22.01% and the public at 26.36%. With reserves of ₹2,173 Cr. and manageable borrowings of ₹131 Cr., Cartrade Tech appears financially stable with a comfortable ICR of 19.12x. The P/BV ratio of 3.51x suggests a premium valuation. Investors should monitor how the company leverages its strengths to drive future growth and sustain shareholder value.

Competitors of Cartrade Tech Ltd

All Competitor Stocks of Cartrade Tech Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:40 am

Below is a detailed analysis of the quarterly data for Cartrade Tech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2025) to 173.00 Cr., marking an increase of 3.00 Cr..
• For Expenses, as of Jun 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 123.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 7.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Mar 2025) to 44.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 27.00% (Mar 2025) to 25.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 57.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 17.00%. The value appears to be increasing, which may not be favorable. It has increased from 14.00% (Mar 2025) to 17.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.03. The value appears strong and on an upward trend. It has increased from 8.82 (Mar 2025) to 9.03, marking an increase of 0.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:04 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:37 pm

Below is a detailed analysis of the balance sheet data for Cartrade Tech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 47.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 47.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,173.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,023.00 Cr. (Mar 2024) to 2,173.00 Cr., marking an increase of 150.00 Cr..
• For Borrowings, as of Mar 2025, the value is 131.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 112.00 Cr. (Mar 2024) to 131.00 Cr., marking an increase of 19.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 326.00 Cr. (Mar 2024) to 353.00 Cr., marking an increase of 27.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,705.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,508.00 Cr. (Mar 2024) to 2,705.00 Cr., marking an increase of 197.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,497.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,489.00 Cr. (Mar 2024) to 1,497.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 614.00 Cr.. The value appears strong and on an upward trend. It has increased from 510.00 Cr. (Mar 2024) to 614.00 Cr., marking an increase of 104.00 Cr..
• For Other Assets, as of Mar 2025, the value is 594.00 Cr.. The value appears strong and on an upward trend. It has increased from 509.00 Cr. (Mar 2024) to 594.00 Cr., marking an increase of 85.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,705.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,508.00 Cr. (Mar 2024) to 2,705.00 Cr., marking an increase of 197.00 Cr..

Notably, the Reserves (2,173.00 Cr.) exceed the Borrowings (131.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Cartrade Tech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 28.48. This value is within the healthy range. It has increased from 3.05 (Mar 24) to 28.48, marking an increase of 25.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 26.42. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 26.42, marking an increase of 23.61.
• For Cash EPS (Rs.), as of Mar 25, the value is 39.23. This value is within the healthy range. It has increased from 12.23 (Mar 24) to 39.23, marking an increase of 27.00.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 468.11. It has increased from 441.48 (Mar 24) to 468.11, marking an increase of 26.63.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 468.11. It has increased from 441.48 (Mar 24) to 468.11, marking an increase of 26.63.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 135.15. It has increased from 104.49 (Mar 24) to 135.15, marking an increase of 30.66.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 46.46. This value is within the healthy range. It has increased from 30.86 (Mar 24) to 46.46, marking an increase of 15.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 37.85. This value is within the healthy range. It has increased from 22.88 (Mar 24) to 37.85, marking an increase of 14.97.
• For PBT / Share (Rs.), as of Mar 25, the value is 35.42. This value is within the healthy range. It has increased from 20.91 (Mar 24) to 35.42, marking an increase of 14.51.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.62. This value is within the healthy range. It has increased from 4.26 (Mar 24) to 30.62, marking an increase of 26.36.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.38. This value is within the healthy range. It has increased from 3.05 (Mar 24) to 28.38, marking an increase of 25.33.
• For PBDIT Margin (%), as of Mar 25, the value is 34.37. This value is within the healthy range. It has increased from 29.52 (Mar 24) to 34.37, marking an increase of 4.85.
• For PBIT Margin (%), as of Mar 25, the value is 28.00. This value exceeds the healthy maximum of 20. It has increased from 21.89 (Mar 24) to 28.00, marking an increase of 6.11.
• For PBT Margin (%), as of Mar 25, the value is 26.20. This value is within the healthy range. It has increased from 20.00 (Mar 24) to 26.20, marking an increase of 6.20.
• For Net Profit Margin (%), as of Mar 25, the value is 22.65. This value exceeds the healthy maximum of 10. It has increased from 4.07 (Mar 24) to 22.65, marking an increase of 18.58.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 21.00. This value exceeds the healthy maximum of 20. It has increased from 2.91 (Mar 24) to 21.00, marking an increase of 18.09.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.06. This value is below the healthy minimum of 15. It has increased from 0.69 (Mar 24) to 6.06, marking an increase of 5.37.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.32. This value is below the healthy minimum of 10. It has increased from 4.73 (Mar 24) to 7.32, marking an increase of 2.59.
• For Return On Assets (%), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 5. It has increased from 0.56 (Mar 24) to 4.97, marking an increase of 4.41.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.24. It has increased from 0.20 (Mar 24) to 0.24, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 3.70. This value exceeds the healthy maximum of 3. It has increased from 3.33 (Mar 24) to 3.70, marking an increase of 0.37.
• For Quick Ratio (X), as of Mar 25, the value is 3.70. This value exceeds the healthy maximum of 2. It has increased from 3.33 (Mar 24) to 3.70, marking an increase of 0.37.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 19.12. This value is within the healthy range. It has increased from 15.65 (Mar 24) to 19.12, marking an increase of 3.47.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.57. This value is within the healthy range. It has increased from 9.88 (Mar 24) to 13.57, marking an increase of 3.69.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,825.22. It has increased from 2,975.83 (Mar 24) to 7,825.22, marking an increase of 4,849.39.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.21. This value exceeds the healthy maximum of 3. It has increased from 6.07 (Mar 24) to 12.21, marking an increase of 6.14.
• For EV / EBITDA (X), as of Mar 25, the value is 35.50. This value exceeds the healthy maximum of 15. It has increased from 20.57 (Mar 24) to 35.50, marking an increase of 14.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 12.16. This value exceeds the healthy maximum of 3. It has increased from 6.10 (Mar 24) to 12.16, marking an increase of 6.06.
• For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 1.44 (Mar 24) to 3.51, marking an increase of 2.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.16. This value exceeds the healthy maximum of 3. It has increased from 6.10 (Mar 24) to 12.16, marking an increase of 6.06.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness